The HPV vaccine as an adult — still worth it?
For a long time, the HPV vaccine was a topic for teenagers. Today we know that adults can benefit too — though how much varies from person to person.
The official recommendation first: Germany’s Standing Committee on Vaccination (STIKO) recommends the vaccine for girls and boys between 9 and 14, with catch-up vaccination until the 18th birthday. Beyond that, the general recommendation ends — but the vaccines’ approval does not. Vaccination in adulthood is possible and can be worthwhile; it then becomes an individual decision that deserves honest counseling.
The reason for the age limit is sober: the vaccine works preventively, not therapeutically. It protects against HPV types you have not yet encountered — and the more years of sexual activity lie behind you, the more likely such contact has already happened. But hardly anyone has encountered all the relevant types. The current vaccine covers nine of them, and against those still “unknown” to your immune system, it can continue to protect adults as well.
In some situations, the question deserves particular thought — after the end of a long relationship, for instance, when new partners lie ahead, or after a conization due to cell changes: here, studies suggest that vaccination may lower the risk of recurring changes. It is not a guarantee, and it does not treat an existing infection.
Just as important is what the vaccine does not replace: screening. The annual appointment remains, as does the Pap smear — from age 35 combined with an HPV test every three years. Vaccination lowers the risk; it does not remove it.
Which leaves the question of cost. Until the 18th birthday, statutory insurers pay; after that, many insurers cover the vaccine voluntarily as an optional benefit — it is worth asking, otherwise it is a self-pay service. Whether vaccination makes sense in your situation is something we can clarify in a short conversation, ideally as part of your annual checkup — and we are happy to help with the inquiry to your insurer.
The vaccine does not replace screening — it complements it.

